Alopecia Areata Registry
NCT00069589 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3100
Last updated 2019-05-14
Summary
Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
Conditions
- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis
- Autoimmune Hair Loss
- Alopecia Partialis
Sponsors & Collaborators
-
National Alopecia Areata Foundation
collaborator OTHER -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Madeleine Duvic, MD · M.D. Anderson Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-11-30
- Primary Completion
- 2099-11-30
- Completion
- 2099-11-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
NCT05910138 ·Status: UNKNOWN ·Phase: NA
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
NCT06562270 ·Status: RECRUITING
-
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
NCT05098600 ·Status: COMPLETED
-
Healthcare Disparities in Alopecia Areata
NCT05727306 ·Status: COMPLETED
-
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
NCT04239521 ·Status: COMPLETED
-
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
NCT05745389 ·Status: RECRUITING
-
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
NCT02018042 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
NCT03359356 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
NCT06531109 ·Status: RECRUITING
-
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
NCT01950780 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
NCT01917058 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
NCT04011748 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240 ·Status: RECRUITING ·Phase: PHASE3
-
The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
NCT00999869 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser
NCT06239324 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
NCT06854432 ·Status: TERMINATED ·Phase: NA
-
Androgenetic Alopecia in Fabry Disease
NCT01295008 ·Status: COMPLETED
-
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
NCT06564805 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
NCT01385839 ·Status: TERMINATED ·Phase: NA
-
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
NCT07200128 ·Status: COMPLETED
-
Alefacept in Patients With Severe Scalp Alopecia Areata
NCT00167102 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata
NCT01246284 ·Status: COMPLETED ·Phase: NA
-
PAI-1 Expression in Non-scarring Hair Loss
NCT02548689 ·Status: TERMINATED
-
Pharmacogenomic Study of Androgenetic Alopecia
NCT01227031 ·Status: UNKNOWN